Plutux
$39.25
-0.30%
2026-09-04 11:55:49 EDT-$0.12
Healthcare
Biotechnology
NASDAQ
Active Trading

Celldex Therapeutics, Inc. is a biopharmaceutical company dedicated to developing antibody-based treatments, specifically monoclonal and bispecific antibodies, for a range of diseases. ...

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer

© Plutux Technology Limited 2026
Celldex Therapeutics, Inc. (CLDX) employee count and workforce trend